Jarreau C - Search Results

1

Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging.

Wang Y, Liu Y, Luehmann H, Xia X, Brown P, Jarreau C, Welch M, Xia Y. Wang Y, et al. Among authors: jarreau c. ACS Nano. 2012 Jul 24;6(7):5880-8. doi: 10.1021/nn300464r. Epub 2012 Jun 19. ACS Nano. 2012. PMID: 22690722 Free PMC article.

2

Nucleic Acid-directed Self-assembly of Multifunctional Gold Nanoparticle Imaging Agents.

Zhang Z, Liu Y, Jarreau C, Welch MJ, Taylor JS. Zhang Z, et al. Among authors: jarreau c. Biomater Sci. 2013 Oct;1(10):1055-1064. doi: 10.1039/C3BM60070J. Biomater Sci. 2013. PMID: 24058728 Free PMC article.

3

Low blood cholesterol and low platelet serotonin levels in violent suicide attempters.

Alvarez JC, Cremniter D, Lesieur P, Gregoire A, Gilton A, Macquin-Mavier I, Jarreau C, Spreux-Varoquaux O. Alvarez JC, et al. Among authors: jarreau c. Biol Psychiatry. 1999 Apr 15;45(8):1066-9. doi: 10.1016/s0006-3223(98)00160-7. Biol Psychiatry. 1999. PMID: 10386194

4

[Sweat test].

Marchand M, Jarreau C, Chauffert M, Garcia I, Asselin D, Thouvenot JP, Genest AF. Marchand M, et al. Among authors: jarreau c. Ann Biol Clin (Paris). 1998 Mar-Apr;56(2):215-21. Ann Biol Clin (Paris). 1998. PMID: 9754252 Free article. French. No abstract available.

5

[Hypercalcemia revealing IgD myeloma].

Mayeur D, Gruyer P, Jarreau C, Dubrujeaud J. Mayeur D, et al. Among authors: jarreau c. Presse Med. 1992 Nov 7;21(37):1774. Presse Med. 1992. PMID: 1488423 French. No abstract available.

6

Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administration.

Lecocq B, Jaillon P, Lecocq V, Ferry A, Gardin ME, Jarreau C, Leroyer R, Pays M, Jarreau FX. Lecocq B, et al. Among authors: jarreau c. J Cardiovasc Pharmacol. 1988 Oct;12(4):445-50. doi: 10.1097/00005344-198810000-00010. J Cardiovasc Pharmacol. 1988. PMID: 2465445 Clinical Trial.

7

Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.

Jaillon P, Poirier JM, Lecocq B, Jarreau C, Pays M, Richard MO, Cheymol G. Jaillon P, et al. Among authors: jarreau c. Eur J Drug Metab Pharmacokinet. 1986 Jul-Sep;11(3):233-8. doi: 10.1007/BF03189851. Eur J Drug Metab Pharmacokinet. 1986. PMID: 3816879 Clinical Trial.

8

[Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].

Leroyer R, Varoquaux O, Guillebastres R, Jarreau C, Normand JP, Jaillon P, Advenier C, Pays M. Leroyer R, et al. Among authors: jarreau c. Therapie. 1986 May-Jun;41(3):159-62. Therapie. 1986. PMID: 3750253 French. No abstract available.

9

Reverse-phase liquid chromatography and pharmacokinetic study of two hydroxylated analogues of quinidine in dogs.

Leroyer R, Jarreau C, Pays M, Varoquaux O, Advenier C. Leroyer R, et al. Among authors: jarreau c. J Pharm Sci. 1984 Jun;73(6):844-6. doi: 10.1002/jps.2600730640. J Pharm Sci. 1984. PMID: 6547483

10

[Quinidine and enzyme induction. Erroneous interpretation of the plasma levels of 3-hydroxyquinidine and O-demethylquinidine].

Leroyer R, Jarreau C, Pays M. Leroyer R, et al. Among authors: jarreau c. Therapie. 1984 Jan-Feb;39(1):57-9. Therapie. 1984. PMID: 6463946 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters